000 -LEADER |
fixed length control field |
01358cam a2200397 a 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION |
control field |
20150712005515.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
031029s2003 nyua b 001 0 eng |
010 ## - LIBRARY OF CONGRESS CONTROL NUMBER |
LC control number |
2003279593 |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
0824708385 |
040 ## - CATALOGING SOURCE |
Original cataloging agency |
DLC |
Language of cataloging |
eng |
Transcribing agency |
DLC |
Modifying agency |
DLC |
043 ## - GEOGRAPHIC AREA CODE |
Geographic area code |
n-us--- |
050 00 - LIBRARY OF CONGRESS CALL NUMBER |
Classification number |
RS189 |
Item number |
.P46 2003 |
060 ## - NATIONAL LIBRARY OF MEDICINE CALL NUMBER |
Item number |
NP |
082 00 - DEWEY DECIMAL CLASSIFICATION NUMBER |
Classification number |
615.10685 |
Edition number |
22 |
084 ## - OTHER CLASSIFICATION NUMBER |
Classification number |
615.10685 |
Item number |
NP |
001 - CONTROL NUMBER |
control field |
0000048898 |
003 - CONTROL NUMBER IDENTIFIER |
control field |
0000 |
100 1# - MAIN ENTRY--PERSONAL NAME |
Personal name |
Nash Robert A. |
245 10 - TITLE STATEMENT |
Title |
Pharmaceutical process validation |
Medium |
[[Book] /] |
Statement of responsibility, etc. |
edited by Robert A. Nash, Alfred H. Wachter. |
250 ## - EDITION STATEMENT |
Edition statement |
3rd ed., rev. and expanded. |
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
Place of publication, distribution, etc. |
New York : |
Name of publisher, distributor, etc. |
Marcel Dekker, |
Date of publication, distribution, etc. |
2003. |
300 ## - PHYSICAL DESCRIPTION |
Extent |
xxxvi, 860 p. : |
Other physical details |
ill. ; |
Dimensions |
24 cm. |
490 1# - SERIES STATEMENT |
Series statement |
Drugs and the pharmaceutical sciences ; |
Volume/sequential designation |
129 |
504 ## - BIBLIOGRAPHY, ETC. NOTE |
Bibliography, etc |
Includes bibliographical references and index. |
521 ## - TARGET AUDIENCE NOTE |
Target audience note |
All Ages. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Pharmaceutical industry |
General subdivision |
Quality control. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Drugs |
General subdivision |
Standards |
Geographic subdivision |
United States. |
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Drug Evaluation |
General subdivision |
standards |
Geographic subdivision |
United States. |
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Drug Industry |
General subdivision |
standards |
Geographic subdivision |
United States. |
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Quality Control. |
700 1# - ADDED ENTRY--PERSONAL NAME |
Personal name |
Nash, Robert A., |
Dates associated with a name |
1930- |
700 1# - ADDED ENTRY--PERSONAL NAME |
Personal name |
Berry, Ira R., |
Dates associated with a name |
1942- |
830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE |
Uniform title |
Drugs and the pharmaceutical sciences ; |
Volume number/sequential designation |
v. 129. |
856 42 - ELECTRONIC LOCATION AND ACCESS |
Materials specified |
Publisher description |
Uniform Resource Identifier |
http://www.loc.gov/catdir/enhancements/fy0647/2003279593-d.html |
942 ## - ADDED ENTRY ELEMENTS (KOHA) |
Koha item type |
Books |